Orange Book product · Brand (NDA)

TIGECYCLINE

Brand (NDA)NDA 211158TE APRX AMNEAL

Aug 02, 2018

Approved

Brand (NDA)

Application

TE code

Listed patents

Approval
FDA approval date of this drug product.
Aug 02, 2018
8 yr ago
Today
Patent 9855335 expires
Listed drug product patent expiration.
Apr 07, 2033
in 6 yr 11 mo

Active ingredient

TIGECYCLINE

Strength

50MG/VIAL

Dosage form

POWDER

Route

INTRAVENOUS

TE code

Application

NDA 211158

Product number

001

Marketing status

Reference listed drug (RLD)

Reference standard (RS)

Active-ingredient family

This is a brand (NDA) product. Other products sharing this active ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
9855335	Apr 07, 2033	in 6 yr 11 mo	Product